1. Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors. Issue 4 (27th April 2022) Authors: Pipe, Steven W.; Hermans, Cédric; Chitlur, Meera; Carcao, Manuel; Castaman, Giancarlo; Davis, Joanna A.; Ducore, Jonathan; Dunn, Amy L.; Escobar, Miguel; Journeycake, Janna; Khan, Osman; Mahlangu, Johnny; Meeks, Shannon L.; Mitha, Ismail Haroon; Négrier, Claude; Nowak‐Göttl, Ulrike; Recht, Michae... Journal: Haemophilia Issue: Volume 28:Issue 4(2022) Page Start: 548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors. Issue 6 (6th October 2021) Authors: Escobar, Miguel; Luck, James; Averianov, Yevhenii; Ducore, Jonathan; Fernández, Maria Fernanda López; Giermasz, Adam; Hart, Daniel P.; Journeycake, Janna; Kessler, Craig; Leissinger, Cindy; Mahlangu, Johnny; Martinez, Laura Villarreal; Miesbach, Wolfgang; Mitha, Ismail Haroon; Quon, Doris; Reding... Journal: Haemophilia Issue: Volume 27:Issue 6(2021) Page Start: 911 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗